Paxlovid, an antiviral treatment for Covid-19, was hailed as a game-changer in the pandemic thanks to its strong performance in lowering the risk of severe disease. Early supply challenges have ...

"Paxlovid is not a drug that gets you better faster. It's not a drug that decreases long COVID," Adalja said. "It's a drug that prevents you from being hospitalized or dying." ...

Paxlovid, an antiviral therapy that is prescribed to COVID-19 patients to prevent severe illness, soon will cost more than double the $529 that the federal government had paid for the treatment.

Everything we know about Paxlovid, the COVID-19 pill that’s saving lives Experts explain how the drug works, where it came from, and what kinds of side effects to expect ...

Item 1 of 2 Paxlovid, Pfizer's anti-viral medication to treat the coronavirus disease (COVID-19), is displayed in this picture illustration taken in Medford, Massachusetts, U.S., May 12, 2022.

Paxlovid, available since December 2021, reduced the COVID-19 death rate in high-risk patients by 73%, according to a study National Institutes of Health researchers released last year. Yet uptake ...

State-licensed pharmacists can now prescribe Paxlovid, alongside doctors, as a COVID-19 treatment for people who are eligible to receive it, the FDA says.

Pfizer, Paxlovid’s manufacturer, found in its own study of the drug that rebound occurs in about 1.7% of Paxlovid patients, which is slightly lower than what they found in the untreated, ...

A U.S. Food and Drug Administration analysis did not find a clear association between the COVID-19 antiviral drug Paxlovid and illness rebound, the FDA said in a new report.. Rebound rates are ...

Though Paxlovid has been proven effective in reducing hospitalizations and deaths in high-risk Covid patients, some people have become wary of the medication because a small percentage of patients ...